Nervous System Diseases: Clinical Trials

18 trials for Nervous System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 suspended. 18 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Suspended 18
Phase 26Suspended 6

Follow Nervous System Diseases: new trials by email Literature Review of Nervous System Diseases trials Research Report on Nervous System Diseases

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of F14 Following Total Knee Replacement
F14 (sustained release celecoxib) - Analgesia
Phase 2 / Phase 3SuspendedArthritis Innovation Corporation1002027-01-012026-06-05
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Placebo, Masitinib (4.5) - Progressive Multiple Sclerosis
Phase 3SuspendedAB Science8002022-06-282026-05-06
The NIPA Study Naloxegol Administration to Prevent Opioids Induced Gastrointestinal Motility Disturbance in Brain Injured PAtients
Naloxegol, Placebo - Brain Injuries
Phase 3SuspendedUniversity Hospital, Brest3702022-03-152026-06-16
CBD Oil for Reducing Emotional Impact of COVID-19
CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse
Phase 2 / Phase 3SuspendedUniversity of Texas at Austin2002020-12-042023-11-22
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease
GV-971, Placebo - Alzheimer Disease
Phase 3SuspendedGreen Valley (Shanghai) Pharmaceuticals Co., Ltd.20462020-10-272022-11-23
Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks
Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide., Acetaminophen - Migraine
Phase 3SuspendedAche Laboratorios Farmaceuticos S.A.3362020-04-012019-04-10
Effects of 5HTP and LDOPA on CNS Excitability After SCI
5HTP, L-DOPA, Placebo oral tablet - Spinal Cord Injuries
Phase 2 / Phase 3SuspendedJessica M D'Amico302019-06-192022-10-17
A Novel Approach to Infantile Spasms
Cosyntropin Injectable Suspension, 1 mg/mL, Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin, Vigabatrin - Infantile Spasm
Phase 3SuspendedUniversity of Colorado, Denver3942018-04-192021-05-27
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury
ES135 - Spinal Cord Injuries
Phase 3SuspendedEusol Biotech Co., Ltd.1602018-03-072024-05-08
Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy
selective brain cooling by cold saline perfusion, mechanical thrombectomy - Hypothermia, Stroke, Acute
Phase 2 / Phase 3SuspendedCapital Medical University1202018-02-062020-08-04
Target Hemodynamics and Brain Injury During General Anesthesia in the Elderly
Hemodynamic target, Phenylephrine, Intravenous fluids - Post-operative Cognitive Dysfunction
Phase 2 / Phase 3SuspendedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico18122014-10-012018-04-13
HOPE-Epilepsy Trial
Omega 3 fatty acids, corn oil - Epilepsy
Phase 2 / Phase 3SuspendedHospital do Coracao3702013-07-012014-02-27
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Asenapine - Stuttering
Phase 3SuspendedUniversity of California, Irvine322012-09-012014-05-20
Caroverin and Inner Ear Diseases
Caroverin - Tinnitus
Phase 3SuspendedPhafag AG1702011-01-012015-08-07
Traumeel S for Reduction of Post Operative Pain Following Arthroscopy
Traumeel S: intra-operative irrigation + oral ingestion, Placebo - Post-operative Pain
Phase 3SuspendedShaare Zedek Medical Center982011-01-012010-10-29
Acupuncture for Phantom Limb Pain
acupuncture, placebo/sham acupuncture - Phantom Limb Pain
Phase 3SuspendedShaare Zedek Medical Center402009-02-012009-02-18
Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)
Liposomal cytarabine, Intrathecal triple - Acute Lymphoblastic Leukemia
Phase 3SuspendedNordic Society for Pediatric Hematology and Oncology1002009-01-012012-10-10
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
ketamine - Alcoholic Patient, Carcinological Surgery ORL
Phase 3SuspendedUniversity Hospital, Clermont-Ferrand562006-04-012008-10-08

Narrower conditions

Agnosia (3)  ·  Epilepsy (2)  ·  Pain, Postoperative (2)  ·  Spinal Cord Injuries (2)  ·  Alcoholism (1)  ·  Alzheimer Disease (1)  ·  Blast Injuries (1)  ·  Brain Injuries (1)  ·  Brain Injuries, Traumatic (1)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Delirium (1)  ·  Fractures, Stress (1)  ·  Headache (1)  ·  Hearing Loss, Sudden (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (11)  ·  Signs and Symptoms (9)  ·  Central Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Brain Diseases (6)  ·  Neurobehavioral Manifestations (6)  ·  Pathologic Processes (5)  ·  Wounds and Injuries (5)  ·  Pain (4)  ·  Perceptual Disorders (4)  ·  Mental Disorders (3)  ·  Postoperative Complications (3)  ·  Trauma, Nervous System (3)  ·  Cardiovascular Diseases (2)

Interventions

Acetaminophen (1)  ·  Acupuncture Therapy (1)  ·  Carbidopa (1)  ·  Corn Oil (1)  ·  Cytarabine (1)  ·  Dopamine (1)  ·  Eating (1)  ·  Ephedrine (1)  ·  Epinephrine (1)  ·  Fatty Acids, Omega-3 (1)  ·  GV-971 (1)  ·  Ketamine (1)  ·  Levodopa (1)  ·  Methylprednisolone (1)  ·  Norepinephrine (1)

Sponsors

Shaare Zedek Medical Center (2)  ·  AB Science (1)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Arthritis Innovation Corporation (1)  ·  Capital Medical University (1)  ·  Eusol Biotech Co., Ltd. (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  Green Valley (Shanghai) Pharmaceuticals Co., Ltd. (1)  ·  Hospital do Coracao (1)  ·  Jessica M D'Amico (1)  ·  Nordic Society for Pediatric Hematology and Oncology (1)  ·  Phafag AG (1)  ·  University Hospital, Brest (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of California, Irvine (1)

Countries

United States (6)  ·  France (4)  ·  Brazil (2)  ·  China (2)  ·  Israel (2)  ·  Italy (2)  ·  Poland (2)  ·  Sweden (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)

Top investigators

Alessandro Santini, MD (1)  ·  Antonio Pesenti, MD (1)  ·  Arja Harila-Saari, MD (1)  ·  F A Scorza, PhD (1)  ·  Gerald Maguire, M.D. (1)  ·  Jared Foran, MD (1)  ·  Jessica D'Amico, PhD (1)  ·  Kelly G. Knupp, MD (1)  ·  Luciano Gattinoni, MD, FRCP (1)  ·  M J Carrion, MD (1)  ·  Menachem Oberbaum, M.D. (1)  ·  Michael J Telch, Ph.D. (1)  ·  Michael Quintel, MD, PhD (1)  ·  Nicolas Rascol, Dr (1)  ·  Noah Samuels, M.D. (1)

Results publications

PMID 30243062, PMID 36048877

NIH funding

2009 (1)